BR
Braxia Scientific Corp.
BRAXF · OTC
$0.00 +0.00% (+$0.00)
1M +9,900.00%
Market Cap $39.2K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.02x
P/B 0.02x
P/E N/A
Growth
78 /100
Growing Rev. growth 1,971.39%
Book val. growth 51.42%
EPS growth N/A
Profitability
1 /100
Weak Gross margin 9.12%
FCF margin 440.60%
Net margin 697.48%
Quality
9 /100
Poor ROIC 408.30%
Asset turnover 0.49x
ROA 338.35%
Debt
55 /100
Moderate Debt/Equity 0.13x
Int. coverage -743.78x
Current ratio 1.00x
Stability
10 /100
Unstable Beta 1.45x
Profitable years 0
Rev. volatility 274,535.87%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na BRAXF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Peter Rizakos
Employees
5
Headquarters
Toronto